ImmunoPrecise Antibodies Set To Begin Trading On Nasdaq December 30

ImmunoPrecise Antibodies (TSXV: IPA) (NASDAQ: IPA) has officially been approved for listing on the Nasdaq Global Markets. The company announced the news this morning, indicating that it will trade under the same symbol that Canadian shareholders are accustomed to, “IPA”.

Trading of ImmunoPrecise’s shares on the Nasdaq is expected to commence on December 30. The company is also expected to remain listed on the TSX Venture exchange as well, under its current symbol.

The announcement follows the firm filing the application for such listing back in September. At the time, the company indicated that it was motivated for the dual listing as a result of the desire to gain greater exposure to both retail and institutional investors in the United States as well as internationally.

ImmunoPrecise Antibodies last traded at $14.76 on the TSX Venture.


Information for this analysis was found via Sedar and ImmunoPrecise Antibodies Ltd. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Euro Sun: Rovina Copper-Gold Project Secures Some Major Funding

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

ImmunoPrecise Begins Pre-Clinical Trials For SARS-CoV-2 Vaccine

ImmunoPrecise Antibodies (TSXV: IPA) and its partner LiteVax BV jointly announced this morning that they...

Friday, September 25, 2020, 08:30:35 AM

ImmunoPrecise Begins Path to NASDAQ

This morning ImmunoPrecise Antibodies Ltd (TSXV: IPA) announced they have commenced the application process to...

Thursday, September 10, 2020, 09:45:18 AM

Market Movers: Canadian Small Cap COVID-19 Stocks Take A Beating

COVID-19 related stocks are all the rage this morning, however it appears to be for...

Monday, November 9, 2020, 10:56:07 AM

ImmunoPrecise Repays $2.75 Million In Debt, Sees $3.8 Million In Warrants Exercised

ImmunoPrecise Antibodies (TSXV: IPA) announced this morning that it has managed to remove outstanding convertible...

Monday, July 20, 2020, 09:21:38 AM

ImmunoPrecise Insider Sells $1.9 Million Worth Of Shares Over Three Days

ImmunoPrecise Antibodies Ltd (TSXV: IPA) has seen continued insider selling over the last several days....

Wednesday, September 16, 2020, 12:17:00 PM